Thermo Fisher Scientific Inc., announced the expansion of cell culture media manufacturing site in Grand Island, New York, to meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics. It’s a dry powder media manufacturing facility that provides the redundant capacity to support a global supply of media needed for the development and commercial manufacturing of vaccines and biological therapies.
Merck KGaA, a leading science and technology company, announced the completion of a USD 2.8 million expansion to its Irvine biopharmaceutical production facility which is Merck’s only location where both liquid and powder cell culture media are manufactured.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?